Just a Little Heart Attack

In honor of heart month, here is the AHA’s “Just a Little Heart Attack” video, starring Elizabeth Banks. It’s a great reminder to women to stop and pay attention to their health.


 

Comments Off

Writing Committee Opportunity – Percutaneous Treatment of CTO

 

The SCAI Publications Committee has approved a new writing committee. Self nominations for participation on the committee are being sought:

  • Prof Alfredo R. Galassi MD, FACC, FESC, FSCAI (Cannizzaro Hospital,
    Italy), University of Catania
    is the nominated Chair.
  • Send self-nominations AND Statement of Interest (brief paragraph will suffice)
    & a current CV to Sheila Agyeman at sagyeman@scai.org.
    SCAI membership is required.
  • If you are aware of any known relationships with Industry (RWI) relevant to this topic please include them in your submission (Particularly with any of the following companies: Asahi Intecc, Terumo, Kensey Nash Corporation, Exton PA, SafeCross, Abbott, Medtronic, J&J, BSC, Bridgepoint)
  • Submission due date is Thursday-FEB 23, 2012
  • Writing Committee is limited to 8 interventional cardiologists, including the Chair.
Comments Off

Wear Red On Friday February 3rd!

Friday, February 3 is National Wear Red day in the US. Don’t forget to wear red in solidarity with the mission of fighting heart disease in women. To read more about the campaign, visit WIN partner, The American Heart Association’s Go Red For Women’s website HERE.

Comments Off

FDA Approves New Labeling for VYTORIN

The Food and Drug Administration (FDA) recently approved new labeling for the cholesterol lowering drug, VYTORIN to include new data from the Study of Heart and Renal Protection (SHARP). The SHARP study showed that VYTORIN effectively lowered cholesterol in patients with severe chronic kidney disease, with fewer major vascular events in patients taking VYTORIN as compared to the placebo.

As it relates to women, this news may not be as rosy. VYTORIN contains simvastatin, which occasionally causes myopathy manifested as muscle pain, tenderness, or weakness with CK levels above 10 times the upper limit of normal (ULN). Myopathy sometimes takes the form of rhabdomyolysis with or without acute renal failure secondary to myoglobinuria, and rare fatalities have occurred. Amongst the predisposing factors for myopathy is female gender.

To read the full article, click HERE.

Comments Off

Writing Committee Opportunity – PCI w/o Onsite Surgery

New writing committee opportunity available:

  • Manuscript Title: The Current Status of PCI without Onsite Surgery: An Update of the 2007 SCAI Expert Consensus Document
  • Chair: Dr. Gregory Dehmer
  • Please send 1) self-nomination 2) Statement of Interest and 3) a current CV to Sheila Agyeman at sagyeman@scai.orgSCAI membership is required.
  • If you have any known relationships with industry (RWI) relevant to this topic please include them in your submission.
  • Due Wednesday, February 1st ; however, all applicants are presented to Chair as first come, first serve.
  • Writing committee is limited to 8 interventional cardiologists, including the Chair.

For more details…

Read more

Comments Off